AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects
- First Posted Date
- 2010-08-05
- Last Posted Date
- 2013-02-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 48
- Registration Number
- NCT01175564
To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes
- First Posted Date
- 2010-08-05
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT01176097
- Locations
- 🇺🇸
Research Site, Chula Vista, California, United States
A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2014-02-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 50
- Registration Number
- NCT01173471
- Locations
- 🇬🇧
Research Site, Nottingham, United Kingdom
Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
Completed
- Conditions
- ACSAcute Coronary SyndromeMyocardial InfarctionUnstable AnginaCoronary Artery Disease
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 10568
- Registration Number
- NCT01171404
- Locations
- 🇻🇪
Research Site, Valencia, Venezuela
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer
Completed
- Conditions
- PostmenopauseBreast Cancer
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2014-02-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 570
- Registration Number
- NCT01171417
- Locations
- 🇩🇪
Research Site, Zittau, Germany
Study to Investigate Multiple Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2015-01-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 73
- Registration Number
- NCT01171105
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2010-07-26
- Last Posted Date
- 2012-05-31
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 684
- Registration Number
- NCT01169727
- Locations
- 🇹🇭
Research Site, Prannok, Bangkok, Thailand
Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma
Completed
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2012-09-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2000
- Registration Number
- NCT01167972
- Locations
- 🇫🇷
Research Site, Yerres, France
A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2013-02-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 56
- Registration Number
- NCT01167868
- Locations
- 🇺🇸
Research Site, Glendale, California, United States
Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy VolunteersSafetyTolerability
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-07-21
- Last Posted Date
- 2011-11-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 100
- Registration Number
- NCT01166698
- Locations
- 🇬🇧
Research Site, London, United Kingdom